SPY313.17+2.65 0.85%
DIA259.28+1.97 0.77%
IXIC10,246.05+91.42 0.90%

CORRECTION: Medifast Reaffirms FY19 Sales Guidance $730M-750M vs $750.45M Est

Benzinga · -